Center for Scientific Review; Notice of Closed Meetings, 17861-17862 [2024-05179]
Download as PDF
<![CDATA[
17861
Federal Register / Vol. 89, No. 49 / Tuesday, March 12, 2024 / Notices
Accomplishments; Broader Program
Impacts; Products and Dissemination;
Collaboration and Partnering Activities;
and Project Evaluation Activities.
Information will be prepopulated based
on the login credentials for the user
submitting the report and the specific
grant being reported. Not all grants will
have reportable activities under all
headings (e.g., not all grants have an
evaluation component embedded in the
project). However, most OASH grants
will have reportable information under
most headings. Program offices with
additional reporting programmatic
information collections will eventually
transition collection of any overlapping
data elements to this OASH PPR. During
the transition, OASH will not require
grant recipients to provide the same
information twice.
Likely Respondents: Members and
staff from academia, community
organizations, local/state/federal
government, private sector, and tribal
government and services organizations.
ANNUALIZED BURDEN HOUR TABLE
OASH PPR .......................................
OASH grant recipients .....................
800
3
1
2400
Total ...........................................
...........................................................
........................
........................
........................
2400
[FR Doc. 2024–05162 Filed 3–11–24; 8:45 am]
BILLING CODE 4150–48–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK X01 Central
Repository Non-renewable Sample Access
review meeting.
Date: April 4, 2024.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7009,
VerDate Sep<11>2014
19:36 Mar 11, 2024
Jkt 262001
Number of
respondents
Average
burden per
response
Respondents
(if necessary)
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses
per
respondents
Forms
(if necessary)
Bethesda, MD 20892, (301) 594–4721,
kozelp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05161 Filed 3–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Fellowship Review
Meeting.
Date: April 5, 2024.
Time: 12:00 p.m. to 1:00 p.m.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Total
burden hours
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Officer,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7347, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7797, connaughtonj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 6, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05160 Filed 3–11–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\12MRN1.SGM
12MRN1
17862
Federal Register / Vol. 89, No. 49 / Tuesday, March 12, 2024 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Integrative Vascular Biology and
Hematology Hypertension.
Date: April 3, 2024.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dmitri V. Gnatenko, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, gnatenkod2@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Atherosclerosis and Vascular
Biology.
Date: April 5, 2024.
Time: 1:00 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bukhtiar H. Shah, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892, (301) 806–
7314, shahb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Adaptive and Innate Immunity
Special Emphasis Panel.
Date: April 5, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Daum, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
Bethesda, MD 20892, 301–827–7233,
susan.boyle-vavra@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 6, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05179 Filed 3–11–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:36 Mar 11, 2024
Jkt 262001
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7090–N–04]
60-Day Notice of Proposed Information
Collection: Moving to Work Stepped
and Tiered Rent Demonstration
Evaluation, OMB Control No.: 2528–
0339
This
notice informs the public that HUD is
seeking approval from OMB for the
information collection described in
Section A.
SUPPLEMENTARY INFORMATION:
A. Overview of Information Collection
Title of Information Collection:
Moving to Work (MTW) Cohort 2
Stepped and Tiered Rent Demonstration
Evaluation.
AGENCY: Office of Policy Development
OMB Approval Number: 2528–0339.
and Research, HUD.
Type of Request: Revision of a
ACTION: Notice.
currently approved collection.
Form Number: N/A.
SUMMARY: HUD is seeking approval from
Description of the need for the
the Office of Management and Budget
information and proposed use: HUD has
(OMB) for the information collection
selected 10 Public Housing Agencies
described below. In accordance with the (PHAs) to participate in the second
Paperwork Reduction Act, HUD is
cohort of the Moving to Work (MTW)
requesting comment from all interested
Expansion, Stepped and Tiered Rent
parties on the proposed collection of
Demonstration (STRD). These PHAs will
information. The purpose of this notice
implement an alternative rent policy (a
is to allow for 60 days of public
stepped rent or tiered rent) that is
comment.
intended to reduce PHA administrative
burden and increase self-sufficiency of
DATES: Comments Due Date: May 13,
assisted households. Five PHAs will
2024.
implement a stepped rent and five PHAs
ADDRESSES: Interested persons are
will implement a tiered rent. HUD’s
invited to submit comments regarding
Office of Policy Development and
this proposal. Written comments and
Research (PD&R) will evaluate the
recommendations for the proposed
information collection can be submitted impacts of those alternative rent
policies, using a randomized controlled
within 60 days of publication of this
trial. The evaluation will rely on data
notice to www.reginfo.gov/public/do/
from a variety of sources, including new
PRAMain. Find this particular
information collection efforts proposed
information collection by selecting,
‘‘Currently under 60-day Review—Open in this Notice. HUD has contracted with
MDRC to conduct the first phase of the
for Public Comments’’ or by using the
evaluation, including random
search function. Interested persons are
assignment, baseline data collection,
also invited to submit comments
and monitoring PHA implementation.
regarding this proposal by name and/or
Within the 10 participating PHAs,
OMB Control Number and can be sent
eligible households will be randomly
to: Anna Guido, Reports Management
assigned to have their rent calculated
Officer, REE, Department of Housing
under the new rules (stepped/tiered
and Urban Development, 451 7th Street
rent) or old rules (the Brooke rent,
SW, Room 8210, Washington, DC
typically 30% of household income).
20410–5000 or email at
Eligible households will be non-elderly,
PaperworkReductionActOffice@
non-disabled participants in the public
hud.gov.
housing and housing choice voucher
FOR FURTHER INFORMATION CONTACT:
program. Prior to random assignment,
Anna Guido, Reports Management
each household will be asked to
Officer, Department of Housing and
complete a baseline information form
Urban Development, 451 7th Street SW, (BIF), review the informed consent
Washington, DC 20410; email;
form, and provide informed consent to
Anna.P.Guido@hud.gov; telephone (202) authorize HUD’s evaluator to use their
402–5535 (this is not a toll-free
data for the evaluation. The BIF will
number). HUD welcomes and is
provide important information not
prepared to receive calls from
otherwise available from HUD’s
individuals who are deaf or hard of
administrative data, such as whether the
hearing, as well as individuals with
household has significant barriers to
speech or communication disabilities.
employment. The BIF will average
To learn more about how to make an
approximately 7 minutes long and
accessible telephone call, please visit
reviewing the consent form is expected
https://www.fcc.gov/consumers/guides/ to take approximately 11 minutes.
MDRC will also conduct interviews
telecommunications-relay-service-trs.
with staff from participating PHAs, to
Copies of available documents
better understand their experience
submitted to OMB may be obtained
implementing the new rent policies. For
from Ms. Guido.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 89, Number 49 (Tuesday, March 12, 2024)]
[Notices]
[Pages 17861-17862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05179]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant
[[Page 17862]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Integrative Vascular Biology and Hematology
Hypertension.
Date: April 3, 2024.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dmitri V. Gnatenko, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Atherosclerosis and Vascular Biology.
Date: April 5, 2024.
Time: 1:00 p.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD
20892, (301) 806-7314, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Adaptive and Innate Immunity Special
Emphasis Panel.
Date: April 5, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Daum, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3202, Bethesda, MD 20892, 301-827-7233,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 6, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-05179 Filed 3-11-24; 8:45 am]
BILLING CODE 4140-01-P
